Efficacy and safety of dalbavancin as suppressive therapy Accéder au pdf ► Beringheli TDupieux-Chabert CGoutelle SRoussel-Gaillard TDhelens CRascle PDoudet CRoux SJavaux CTriffault-Fillit CBraun EFerry TValour Fon behalf of Lyon BJI Study Group Posters 43th Annual Meeting of the European Bone and Joint Infection Society (EBJIS) 2025 Dalbavancinsuppressive therapy